BCL2 and breast carcinoma: The decrease of the poly-ubiquitylated forms of Bcl-2 in cells depleted of BRCA1, independently of PRMT1 expression (Fig. 6E,F), also confirmed that cytosolic BRCA1 might control the stability of Bcl-2 in breast cancer cells.